Vol 13, No 11 (November 30, 2024): Translational Cancer Research

Original Article

Elucidating the molecular and immune interplay between head and neck squamous cell carcinoma and diffuse large B-cell lymphoma through bioinformatics and machine learning
Jing Zheng, Xinxin Li, Xun Gong, Yuan Hu, Min Tang
Translational Cancer Research  
2024;
13
(11)
:5725-5750
.
Construction of ferroptosis and pyroptosis model to assess the prognosis of gastric cancer patients based on bioinformatics
Hanlu Shi, Hongfeng Yao, Yi Zhou, Gaoping Wu, Keyi Li, Lusheng Tang, Chen Yang, Dong Wang, Weidong Jin
Translational Cancer Research  
2024;
13
(11)
:5751-5770
.
Prognostic significance of B cell senescence-associated genes as risk markers in prostate adenocarcinoma
Huaiying Zheng, Wei Jiang, Shaoxing Zhu, Xiaobao Chen
Translational Cancer Research  
2024;
13
(11)
:5771-5783
.
Copper metabolism-related lncRNAs predict prognosis and immune landscape in liver cancer patients
Rui Luo, Shu Huang, Xiaomin Shi, Huan Xu, Jieyu Peng, Wenjie Lei, Shiqi Li, Wei Zhang, Lei Shi, Yan Peng, Xiaowei Tang
Translational Cancer Research  
2024;
13
(11)
:5784-5800
.
Immunogenic cell death-related signature predicts prognosis and immunotherapy efficacy in bladder cancer
Long Guo, Na Chen, Mei Qiu, Juliang Yang, Min Zhou, Fei Liu
Translational Cancer Research  
2024;
13
(11)
:5801-5814
.
Determining new disulfidptosis-associated lncRNA signatures pertinent to breast cancer prognosis and immunological microenvironment
Yifan Zheng, Yufeng Lin, Yongcheng Zhang, Shangjie Liu, Yongxia Yang, Wenbin Huang
Translational Cancer Research  
2024;
13
(11)
:5815-5829
.
Pan-cancer analysis combined with experimental validation revealed that KTN1 is an immunological and prognostic biomarker
Yan Ouyang, Yu Shen, Shengming Lai, Haiyan Huang, Yongsheng Huang, Shuwei Ren
Translational Cancer Research  
2024;
13
(11)
:5830-5844
.
Nomogram for predicting the early death of patients with stage IV ovarian cancer: a retrospective analysis of the SEER database
Pan Chen, Shunjie Zheng, Lin Zhang
Translational Cancer Research  
2024;
13
(11)
:5845-5855
.
Identification of the CD8+ T-cell exhaustion signature of hepatocellular carcinoma for the prediction of prognosis and immune microenvironment by integrated analysis of bulk- and single-cell RNA sequencing data
Jianhui Fan, Qinghua Zhang, Tiancong Huang, Haitao Li, Guoxu Fang
Translational Cancer Research  
2024;
13
(11)
:5856-5872
.
Development of a risk prediction model for personalized assessment of postoperative recurrence risk in colon cancer patients
Jing-Jing Zhang, Ya-Meng Liu, Ya-Wei Li, Zheng-Quan Han
Translational Cancer Research  
2024;
13
(11)
:5873-5882
.
Prognostic signature detects homologous recombination deficient in glioblastoma
Dongdong Luo, Aiping Luo, Su Hu, Hailin Zhao, Xuefeng Yao, Dan Li, Biao Peng
Translational Cancer Research  
2024;
13
(11)
:5883-5897
.
The relationship between marital status and survival in primary bone cancer: a population-based study
Xiaoxia Huang, Leilei Tian, Chuang Li, Jinling Liu, Rui Shi, Fang Lin, Yi Luo
Translational Cancer Research  
2024;
13
(11)
:5898-5908
.
Construction of a disulfidptosis-related lncRNAs signature of the subtype, prognostic, and immunotherapy in neuroblastoma
Yongcheng Fu, Nan Zhang, Jingyue Wang, Yuanyuan Wang, Da Zhang
Translational Cancer Research  
2024;
13
(11)
:5909-5928
.
Alpha-fetoprotein-to-PIVKA-II ratio as a potential biomarker for hepatocellular carcinoma differentiation, imaging characteristics, and patient survival
Menene Nkonika Dieu-Merci, Jihong Hu, Xinyi Fang, Renjie Zhao, Xiaojie Xie, Wenqiu Pan, Thapa Aayush, Fang Yin, Hu Xingyue, Dan Han
Translational Cancer Research  
2024;
13
(11)
:5929-5942
.
Development of prediction models for liver metastasis in colorectal cancer based on machine learning: a population-level study
Yuncan Xing, Guanhua Yu, Zheng Jiang, Zheng Wang
Translational Cancer Research  
2024;
13
(11)
:5943-5952
.
Bioinformatics analysis reveals VEGFC’s prognostic significance in head and neck squamous cell carcinoma and its association with immune cell infiltration
Yulian Tang, Ting Hu, Wenli Yin, Changqiao Huang, Dewen Liu, Fengming Lai, Chengliang Yang, Lizhu Tang
Translational Cancer Research  
2024;
13
(11)
:5953-5970
.
Exploring potential causal genetic variants and genes for endometrial cancer: Open Targets Genetics, Mendelian randomization, and multi-tissue transcriptome-wide association analysis
Guorui Zhang, Su Mao, Guangwei Yuan, Yang Wang, Jingyun Yang, Yuxin Dai
Translational Cancer Research  
2024;
13
(11)
:5971-5982
.
Dephosphorylation-related signature predicts the prognosis of papillary renal cell carcinoma
Jia Feng, Longyang Jiang, Hui Tang, Yuankai Si, Li Luo, Jing Liu, Dengmin Hu, Yilan Huang
Translational Cancer Research  
2024;
13
(11)
:5983-5994
.
Prognostic analysis of SYTL4 in acute myeloid leukemia
Kun-Ying Xie, Jin Wei
Translational Cancer Research  
2024;
13
(11)
:5995-6003
.
The prognosis and treatment consideration for non-small cell lung carcinoma patients with tumor size of >2.0–3.0 cm and visceral pleural invasion: a SEER-based study
Xirui Lin, Haijie Xu, Jianrong Chen, Jiaying Wu, Jiong Lin, Hansheng Wu
Translational Cancer Research  
2024;
13
(11)
:6004-6017
.
Therapy-related myeloid neoplasms in Korean patients with ovarian or primary peritoneal cancer treated with poly(ADP-ribose) polymerase inhibitors
Yoon Jung Jang, Heyjin Kim, Sang-Young Ryu, Moon-Hong Kim, Beob-Jong Kim, Hee Jung Jung, Jisik Kang, Sung Hyun Yang, Im Il Na, Hyo-Rak Lee, Hye Jin Kang
Translational Cancer Research  
2024;
13
(11)
:6018-6027
.
Multi-omics decipher the immune microenvironment and unveil therapeutic strategies for postoperative ovarian cancer patients
Zhibing Liu, Fei Wang, Weiwei Chen, Yujie Zhai, Jinbo Jian, Xiaole Wang, Yingjiang Xu, Jiajia An, Lei Han
Translational Cancer Research  
2024;
13
(11)
:6028-6044
.
Comparison of postoperative radiotherapy and definitive radiotherapy for non-metastatic adenoid cystic carcinoma of the head and neck, a propensity score matching based on the SEER database
Mingyu Tan, Yanliang Chen, Tianqi Du, Qian Wang, Xun Wu, Xiaohu Wang, Hongtao Luo, Shilong Sun, Qiuning Zhang, Wenzhen Yuan
Translational Cancer Research  
2024;
13
(11)
:6045-6056
.
SKA1/2/3 link to poor prognosis and immune infiltration of head and neck squamous cell carcinomas
Churen Zhang, Jianguo Ke, Jia Li, Qiaoling Cai
Translational Cancer Research  
2024;
13
(11)
:6057-6069
.
Potential role of TWIST1 and its methylation in bladder urothelial carcinoma
Meixuan Wan, Hongxue Meng, Huining Li
Translational Cancer Research  
2024;
13
(11)
:6070-6086
.
Neuroepithelial cell transforming 1 as a key regulator in non-small cell lung cancer: unveiling causal links and therapeutic potentials
Xiaoqing Shangguan, Xinping Zhang, Xiwu Chen, Zheng Zhang, Lei Wang
Translational Cancer Research  
2024;
13
(11)
:6087-6104
.
Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes
João Agostinho Machado-Neto, Hugo Passos Vicari, Jean Carlos Lipreri da Silva, Maria Fernanda Lopes Carvalho, Keli Lima
Translational Cancer Research  
2024;
13
(11)
:6105-6116
.
Construction and validation of a novel prognostic model with palmitoylation-related genes for glioblastoma
Guowen Qin, Gang Pang, Shuaishuai Wu, Shuiqing Bi, Shengyong Lan, Xiuwen Tang, Beiquan Hu, Junlin Zhou, Fengning Shi, Chengjian Qin
Translational Cancer Research  
2024;
13
(11)
:6117-6135
.
A novel immune-related gene prognostic signature combining immune cell infiltration and immune checkpoint for glioblastoma patients
Xu Liu, Xiaomei Liu
Translational Cancer Research  
2024;
13
(11)
:6136-6153
.
Epidemiological characteristics of myxopapillary ependymoma and factors affecting overall survival: a SEER-based analysis
Ge Huang, Zhengyuan Xie, Jinhong Li
Translational Cancer Research  
2024;
13
(11)
:6154-6164
.
A lncRNA signature associated with endoplasmic reticulum stress supports prognostication and prediction of drug resistance in acute myelogenous leukemia
Yu Fu, Shupeng Wang, Lingyu Meng, Yahui Liu
Translational Cancer Research  
2024;
13
(11)
:6165-6181
.
Integrative multi-omics and machine learning approach reveals tumor microenvironment-associated prognostic biomarkers in ovarian cancer
Wenzhi Jiao, Shasha Yang, Yue Li, Yu Li, Shanshan Liu, Jianwei Shi, Minmin Yu
Translational Cancer Research  
2024;
13
(11)
:6182-6200
.
ABALON regulates mitophagy and 5-FU sensitivity in colorectal cancer via PINK1-Parkin pathway
Huimin Liu, Ying Huang, Chunmei Zhao, Guihua Wang, Xudong Wang
Translational Cancer Research  
2024;
13
(11)
:6201-6218
.
The expression and prognostic value of IFIT3 in esophageal squamous cell carcinoma
Jiawang Cao, Qipeng Zhang, Yiwen Xuan, Zhuan Ou, Qinghua Yu, Daoqi Zhu, Enwu Xu
Translational Cancer Research  
2024;
13
(11)
:6219-6234
.
Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancer
Theodore Wang, Jongmyung Kim, Ritesh Kumar, Rebecca A. Deek, Ryan Stephenson, Tina Mayer, Biren Saraiya, Saum Ghodoussipour, Thomas Jang, David Golombos, Vignesh Packiam, Ronald Ennis, Lara Hathout, Salma K Jabbour, Ozan Guler, Cem Onal, Matthew P. Deek
Translational Cancer Research  
2024;
13
(11)
:6235-6245
.
Integrating artificial intelligence in renal cell carcinoma: evaluating ChatGPT’s performance in educating patients and trainees
J. Patrick Mershon, Tasha Posid, Keyan Salari, Richard S. Matulewicz, Eric A. Singer, Shawn Dason
Translational Cancer Research  
2024;
13
(11)
:6246-6254
.
FLT3 mutation-related immune checkpoint molecule absent in melanoma 2 (AIM2) contributes to immune infiltration in pediatric and adult acute myeloid leukemia: evidence from bioinformatics analysis
Jing Zhao, Yue Cui, Hua Zhou, Dongming Zhou, Zhiping Che, Ning Zhang, Qi Yun, João Agostinho Machado-Neto, Daniela Damiani, Lika’a Fasih Y. Al-Kzayer, Rohan Kulkarni, Meng Gu
Translational Cancer Research  
2024;
13
(11)
:6255-6272
.
PARP1 promotes tumor proliferation in lenalidomide-resistant multiple myeloma via the downregulation of microRNA-192-5p-AKT signaling
Yuqing Luo, Yalu Chen, Cheng Ai, Xiaguang Huang, Fabiana Perna, Brandon J. Kale, Say Min Lim, Meier Gu, Panpan Gao, Chunmeng Rong, Zefeng Zhou, Yiqin Weng, Yinyan Jiang, Fang Yang, Yongming Xia
Translational Cancer Research  
2024;
13
(11)
:6273-6281
.
Novel cuprotosis-related gene signature: a prognostic indicator and regulator of the glioma immune microenvironment
Dongming Gao, Lin Zhou, Youyuan Bao, Wenyin Shi, Lei Li, Liang Gao
Translational Cancer Research  
2024;
13
(11)
:6282-6297
.
Increased expression of HBXIP (LAMTOR5) predicts poor prognosis and is correlated with immune-cell infiltration in glioma
Linyang Shi, Hui Chen, Junmin Chen, Joshua D. Palmer, Lin Wang, Li Sheng
Translational Cancer Research  
2024;
13
(11)
:6298-6314
.
SLC1A3 knockdown in inhibiting the proliferation, apoptosis resistance, and migration of ovarian cancer cells
Wu Zhou, Yanqiang Xiong, Liangping Zhao, Gabriel Levin, Felipe Batalini, Zhihui Liu, Yuanxue Ma
Translational Cancer Research  
2024;
13
(11)
:6315-6322
.
Postexercise downregulation of NUP155 in regulating non-small cell lung cancer progression via the PTEN/AKT signaling pathway
Jiangang Xu, Liyin Zhang, Menghui Feng, Weijun Hong, Xinming Ye
Translational Cancer Research  
2024;
13
(11)
:6323-6335
.
The efficacy of plasma exosomal miRNAs as predictive biomarkers for PD-1 blockade plus chemotherapy in gastric cancer
Yunqi Hua, Shuang Luo, Qian Li, Ge Song, Xiaoling Tian, Peng Wang, Hongwei Zhu, Shuang Lv, Xinyi Zhang, Zixuan Yang, Geoffrey Ku, Guo Shao
Translational Cancer Research  
2024;
13
(11)
:6336-6346
.
CTNND2 gene expression in melanoma tissues and its effects on the malignant biological functions of melanoma cells
Jiaojiao Qu, Xianfeng Cheng, Mingyan Liu, Qiang Zhang
Translational Cancer Research  
2024;
13
(11)
:6347-6363
.
N-acetyltransferase 10 as a novel prognostic biomarker in papillary renal cell carcinoma: a machine learning and experimental validation study
Liyang Li, Fan Li, Chenghao Zhou, Kangxin Ni, Haiyi Hu, Mingchao Wang, Huan Wang, Lei Gao
Translational Cancer Research  
2024;
13
(11)
:6364-6380
.
GCNT3 promotes the proliferation, apoptosis, invasion, and migration of breast cancer through the PI3K/AKT pathway
Yifan Li, Zhen Ren, Teng Wu, Nannan Zhang, Zhixian He
Translational Cancer Research  
2024;
13
(11)
:6381-6393
.

Brief Report

Sex-based differences in CEACAM5 expression in lung cancer
Gavitt A. Woodard, Emma R. Kane, Nicholas Todorovic, Samantha Prince, Sanja Dacic, Lieping Chen
Translational Cancer Research  
2024;
13
(11)
:6394-6402
.

Review Article

Non-clear cell renal cell carcinoma narrative review: where we are in 2024
Michael J. Pierro, Alexander Gallan, Deepak Kilari
Translational Cancer Research  
2024;
13
(11)
:6403-6412
.
Bladder sparing management for muscle-invasive bladder cancer after a complete clinical response: ready for prime time?—a narrative review
Mann Patel, Kyle Moore, Benjamin L. Lichtbroun, Ryan D. Stephenson, Tina Mayer, Biren Saraiya, David Golombos, Thomas Jang, Vignesh T. Packiam, Saum Ghodoussipour
Translational Cancer Research  
2024;
13
(11)
:6413-6429
.
Winning hearts & minds: prostate cancer outreach and clinical trial enrollment in minority men
Rebecca Anderson, Aleksander Popovic, Matthew Davis, Evan Kovac
Translational Cancer Research  
2024;
13
(11)
:6430-6437
.
Management of translocation carcinomas of the kidney
Yasser Ged, Ardit Feinaj, Ezra Baraban, Nirmish Singla
Translational Cancer Research  
2024;
13
(11)
:6438-6447
.
Adjuvant therapy in renal cell carcinoma (RCC): progress, at last
Andrew N. Bueno, Mark N. Stein, Karie Runcie
Translational Cancer Research  
2024;
13
(11)
:6448-6462
.
Contemporary surgical management of testicular seminoma
Rachel Passarelli, John L. Pfail, Thomas L. Jang
Translational Cancer Research  
2024;
13
(11)
:6463-6472
.
Management strategies for radio-recurrent prostate cancer: a comprehensive review
Syed N. Rahman, Hyung Suk Kim, Lindsey T. Webb, Gabriela M. Diaz, Michael S. Leapman, Preston C. Sprenkle, Joseph M. Brito, Joseph Renzulli, Thomas V. Martin, Patrick Kenney, Isaac Yi Kim
Translational Cancer Research  
2024;
13
(11)
:6473-6488
.
Predicting response to bacillus Calmette-Guerin in high-risk non-muscle invasive bladder cancer
Amir M. Soltani-Tehrani, Aman Kumar, Kamal S. Pohar
Translational Cancer Research  
2024;
13
(11)
:6489-6502
.
Treatment approaches for prostate cancer in sub-Saharan Africa
Brooke Kania, Kirthana Sharma, Pleasure Ramatlho, Peter Vuylsteke, Andrew Ndlovu, Tina Mayer
Translational Cancer Research  
2024;
13
(11)
:6503-6510
.
Perioperative systemic therapy in high-risk renal cell carcinoma following nephrectomy: a narrative review
Adam Khorasanchi, Taylor Goodstein, Shawn Dason, Eric A. Singer, Danielle Zimmerman, Yuanquan Yang
Translational Cancer Research  
2024;
13
(11)
:6511-6528
.
A narrative clinical trials review in the realm of focal therapy for localized prostate cancer
Alon Lazarovich, Vijay Viswanath, Aaron S. Dahmen, Abhinav Sidana
Translational Cancer Research  
2024;
13
(11)
:6529-6539
.
Targeting C797S mutations and beyond in non-small cell lung cancer—a mini-review
Wolfram C. M. Dempke, Klaus Fenchel
Translational Cancer Research  
2024;
13
(11)
:6540-6549
.
Targeting breast cancer resistance protein (BCRP/ABCG2) in cancer
Rouan Chen, Yue Yu, Ruixin Liu, Qian Chen
Translational Cancer Research  
2024;
13
(11)
:6550-6564
.
Immunotherapy for locally advanced and metastatic basal cell carcinoma: a narrative review
Xiaoqing Li, Hongru Wang, Qingli Lu
Translational Cancer Research  
2024;
13
(11)
:6565-6575
.

Case Report

Malignant phyllodes tumor of the breast with bilateral ductal carcinoma in situ and postoperative distant metastasis: a case report
Hongyu Liu, Bin Wang, Yuxingzi Chen
Translational Cancer Research  
2024;
13
(11)
:6576-6583
.
Massive gastrointestinal hemorrhage and iodine-125 seed migration due to hepatogastric fistula: a case report and literature review
Chengjian He, Jing Zhou, Naijian Ge, Xiaofeng Zhang, Xiangdong Wang, Yefa Yang
Translational Cancer Research  
2024;
13
(11)
:6584-6589
.

Editorial Commentary

Identifying biomarkers to predict immune-checkpoint therapy response—is it a reality or a distant dream?
Prashanth Ashok Kumar
Translational Cancer Research  
2024;
13
(11)
:6590-6593
.
The next frontier in breast cancer: genomic co-alteration and its impact on biology and treatment planning
Meredith Li, Eitan Amir
Translational Cancer Research  
2024;
13
(11)
:6594-6597
.

Retraction

Retraction: Matrine reverses the drug resistance of K562/ADM cells to ADM and VCR via promoting autophagy
Zhao Li, Ning Wang, Ting Yue, Lu Liu
Translational Cancer Research  
2024;
13
(11)
:6598
.